Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

451

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Tinubu Service Chiefs
NewsSecurity

Tinubu Replaces Service Chiefs Following Rumours Of Coup, Reigniting Nepotism Claims

President Bola Tinubu has appointed General Olufemi Oluyede as the new Chief...

NewsPoliticsSecurity

At Least Two Dead, Internet Blackout as Election Crackdown Escalates in Cameroon

Opposition protesters across Cameroon have been met with the authorities as tensions...

France Deal
News

France Signs €410m Lagos Deal In Bid To Regain Influence After Humiliating CSS Expulsion

France’s Minister for Europe and Foreign Affairs, Jean-Noël Barrot, has announced a...

NewsWorld

Ghana’s Ex-First Lady Nana Konadu Rawlings Dies at 76

Ghana is mourning the passing of Nana Konadu Agyeman Rawlings, former First...